Strides Pharma Science Limited has announced a board meeting to approve the appointment of Ms. Mukta Arora as an Independent Director for five years starting February 1, 2025, and Mr. Arun Kumar as Non-Executive Director and Chairperson effective April 5, 2025. The shareholders’ approval will be sought via Postal Ballot with e-voting commencing February 18, 2025. This governance enhancement aims to strengthen board diversity, potentially boosting investor sentiment positively, given Mukta’s expertise in pharmaceuticals and Arun’s extensive history with the company. Nonetheless, shareholders should note governance changes may come with execution risks.